Next Article in Journal
Cardiology in a Digital Age: Opportunities and Challenges for e-Health: A Literature Review
Previous Article in Journal
Influence of Periodontal Status and Prosthetic Treatment on Survival and Success Rates in Implant Therapy: A 5-Year Retrospective Follow-Up Study
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Associations between Liver Enzymes, Lifestyle Risk Factors and Pre-Existing Medical Conditions in a Population-Based Cross-Sectional Sample

1
Department of Laboratory Medicine and Medical Research Unit, Seinäjoki Central Hospital and Tampere University, 60220 Seinäjoki, Finland
2
Research Unit of Population Health, Faculty of Medicine, University of Oulu, 90014 Oulu, Finland
3
Infrastructure for Population Studies, Faculty of Medicine, University of Oulu, 90014 Oulu, Finland
4
Department of Psychiatry, Seinäjoki Central Hospital and Tampere University, 33100 Tampere, Finland
5
Department of Public Health and Social Welfare, Finnish Institute for Health and Welfare (THL), 00271 Helsinki, Finland
6
Institute of Public Health and Clinical Nutrition, University of Eastern Finland, 70211 Kuopio, Finland
7
Joint Municipal Authority for North Karelia Social and Health Services, 80210 Joensuu, Finland
*
Author to whom correspondence should be addressed.
J. Clin. Med. 2023, 12(13), 4276; https://doi.org/10.3390/jcm12134276
Submission received: 27 April 2023 / Revised: 20 June 2023 / Accepted: 24 June 2023 / Published: 26 June 2023

Abstract

While alanine aminotransferase (ALT) and gamma-glutamyltransferase (GGT) enzymes are commonly used indicators of liver dysfunction recent studies have suggested that these may also serve as predictive biomarkers in the assessment of extrahepatic morbidity. In order to shed further light on the interactions between serum liver enzyme abnormalities, factors of lifestyle and health status we examined ALT and GGT activities in a population-based sample of 8743 adult individuals (4048 men, 4695 women from the National FINRISK 2002 Study, mean age 48.1 ± 13.1 years) with different levels of alcohol drinking, smoking, physical activity, body weight and the presence or absence of various pre-existing medical conditions. The assessments also included laboratory tests for inflammation, lipid status and fatty liver index (FLI), a proxy for fatty liver. The prevalence of ALT and GGT abnormalities were significantly influenced by alcohol use (ALT: p < 0.0005 for men; GGT: p < 0.0005 for both genders), smoking (GGT: p < 0.0005 for men, p = 0.002 for women), adiposity (p < 0.0005 for all comparisons), physical inactivity (GGT: p < 0.0005; ALT: p < 0.0005 for men, p < 0.05 for women) and coffee consumption (p < 0.0005 for GGT in both genders; p < 0.001 for ALT in men). The total sum of lifestyle risk factor scores (LRFS) influenced the occurrence of liver enzyme abnormalities in a rather linear manner. Significantly higher LRFS were observed in the subgroups of individuals with pre-existing medical conditions when compared with those having no morbidities (p < 0.0005). In logistic regression analyses adjusted for the lifestyle factors, both ALT and GGT associated significantly with fatty liver, diabetes and hypertension. GGT levels also associated with coronary heart disease, angina pectoris, cardiac insufficiency, cerebrovascular disease, asthma and depression. Combinations of abnormal ALT and GGT activities significantly increased the odds for hypertension coinciding with abnormalities in biomarkers of inflammation, lipid status and FLI. The data indicates that ALT and GGT activities readily respond to unfavorable factors of lifestyle associating also with a wide array of pre-existing medical conditions. The data supports close links between both hepatic and extrahepatic morbidities and lifestyle risk factors and may open new insights on a more comprehensive use of liver enzymes in predictive algorithms for assessing mechanistically anchored disease conditions.
Keywords: biomarker; ethanol; hypertension; liver; obesity; physical activity biomarker; ethanol; hypertension; liver; obesity; physical activity

Share and Cite

MDPI and ACS Style

Niemelä, O.; Bloigu, A.; Bloigu, R.; Aalto, M.; Laatikainen, T. Associations between Liver Enzymes, Lifestyle Risk Factors and Pre-Existing Medical Conditions in a Population-Based Cross-Sectional Sample. J. Clin. Med. 2023, 12, 4276. https://doi.org/10.3390/jcm12134276

AMA Style

Niemelä O, Bloigu A, Bloigu R, Aalto M, Laatikainen T. Associations between Liver Enzymes, Lifestyle Risk Factors and Pre-Existing Medical Conditions in a Population-Based Cross-Sectional Sample. Journal of Clinical Medicine. 2023; 12(13):4276. https://doi.org/10.3390/jcm12134276

Chicago/Turabian Style

Niemelä, Onni, Aini Bloigu, Risto Bloigu, Mauri Aalto, and Tiina Laatikainen. 2023. "Associations between Liver Enzymes, Lifestyle Risk Factors and Pre-Existing Medical Conditions in a Population-Based Cross-Sectional Sample" Journal of Clinical Medicine 12, no. 13: 4276. https://doi.org/10.3390/jcm12134276

APA Style

Niemelä, O., Bloigu, A., Bloigu, R., Aalto, M., & Laatikainen, T. (2023). Associations between Liver Enzymes, Lifestyle Risk Factors and Pre-Existing Medical Conditions in a Population-Based Cross-Sectional Sample. Journal of Clinical Medicine, 12(13), 4276. https://doi.org/10.3390/jcm12134276

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop